Drug Use-associated Hospital Encounters Data From Selected Hospitals

The National Hospital Care Survey (NHCS) collects data on patient care in hospital-based settings to describe patterns of health care delivery and use in the United States. Settings include inpatient and emergency departments (EDs). From these data, NHCS contributes information on national public health threats such as the current opioid emergency. The 2022 – 2024 NHCS are not yet fully operational—as a result, data presented here are preliminary and not nationally representative.

Data are from Uniform Bill (UB)-04 administrative claims—27 hospitals submitting inpatient and 20 hospitals submitting ED claims—from April 1, 2022–March 31, 2024. Although not nationally representative, the data provide insight into hospital encounters involving the use of opioids and other drugs. NHCS data submitted from different types of hospitals (general acute and children’s hospitals, among others) provide information from indicators related to hospital encounters due to drug use, such as overall drug use, comorbidities, and drug and multidrug overdose. NHCS data can also be used to report on hospital encounters over time on a monthly basis.

The Figure shows the number of inpatient and ED hospital visits for the 27 hospitals that submitted inpatient data and the 20 hospitals that submitted ED data from April 1, 2022–March 31, 2024.

• 2,187,302 ED encounters and 788,995 inpatient discharges.

Technical Notes

• Data are not nationally representative.
• Less than 1% of all encounters are excluded due to missing sex, age, or diagnosis.

Data provided are from small and large hospitals across the country in urban and rural locations. Information on characteristics of the hospitals that provided UB–04 administrative claims data follow.

Data used in figures are preliminary and have not undergone final edits. The data presented will be updated every 2 months to include data for the remaining months in each calendar year. Results may change in monthly updates and with the release of final NHCS data files.

Percentages of rehabilitation or long term acute hospitals included in this summary are higher compared with percentages in the NHCS hospital frame file. No psychiatric hospitals are eligible for reporting in this summary. Additionally, the percentage of hospitals with 500 or more beds and in the Northeast included in these results are greater than those in the NHCS hospital frame file.

NOTE: The NHCS frame has 27 reporting hospitals and 6,906 total hospitals.

SOURCE: National Center for Health Statistics, National Hospital Care Survey, 2022–2024.

NHCS is designed to collect electronic data from UB–04 administrative claims or electronic health records for all encounters in a calendar year. From 2020-2022, the NHCS nationally representative sample included 608 hospitals. From 2023-2024, the NHCS sample was 601 hospitals. Eligible hospitals from the 50 states and District of Columbia include noninstitutional and nonfederal hospitals with six or more staffed inpatient beds. Information collected includes diagnoses, procedures, demographics, discharge status, and patient identifiers such as name and Social Security number. Hospitals are currently being received into the survey.

Data are provided on hospital care and utilization for drug use for a nonrandom subset of NHCS hospitals, including the occurrence of hospital encounters involving drug use over time, the presence of drug use with co-occurring disorders, the presence of drug use with COVID-19, and the occurrence of drug overdose and multidrug overdose. The figures and tables presented represent different groups depending on the measure of interest.

For more details on NHCS, visit: https://www.cdc.gov/nchs/nhcs/index.htm.